Press
“Elgia Therapeutics is committed to developing novel drugs for the treatment of chronic inflammatory and fibrotic diseases. We’re delighted to welcome our seed investors as we pursue this mission.”
Professor Alan Saltiel
Chief Executive Officer of Elgia
Alan Saltiel, Ph.D., Recognized with ASPET Award for Experimental Therapeutics
The American Society for Pharmacology and Experimental Therapeutics has announced the distinguished winners of the 2021 Scientific Achievement Awards. Alan [...]
Elgia Therapeutics Expands Management Team with Appointment of Stacie S. Canan, Ph.D. as Chief Operating Officer
Dr. Canan Brings 28 Years of Biopharmaceutical Experience, Including Research and Development Roles at Pfizer, Celgene and BMSElgia Therapeutics, a [...]
Elgia Therapeutics Announces New Funding to Develop Novel Treatments for Chronic Inflammatory and Fibrotic Diseases
Elgia Therapeutics, co-founded by multiple renown UCSD and UCSF professors, announced seed funding led by Viva BioInnovator to address [...]